{{Rsnum
|rsid=2094258
|Gene=BIVM-ERCC5
|Chromosome=13
|position=102844409
|Orientation=minus
|GMAF=0.236
|Gene_s=BIVM-ERCC5,ERCC5
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 3.5 | 27.4 | 69.0
| HCB | 14.6 | 47.4 | 38.0
| JPT | 19.5 | 46.0 | 34.5
| YRI | 2.1 | 26.0 | 71.9
| ASW | 3.5 | 21.1 | 75.4
| CHB | 14.6 | 47.4 | 38.0
| CHD | 11.1 | 45.4 | 43.5
| GIH | 3.0 | 32.7 | 64.4
| LWK | 2.8 | 23.9 | 73.4
| MEX | 10.3 | 36.2 | 53.4
| MKK | 5.2 | 37.7 | 57.1
| TSI | 5.0 | 28.7 | 66.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=24353624
|Title=XPG is a novel biomarker of clinical outcome in advanced non-small-cell lung cancer
|OA=1
}}

{{PMID Auto
|PMID=22371296
|Title=Polymorphisms in the XPG gene and risk of gastric cancer in Chinese populations.
}}

{{PMID Auto
|PMID=23211354
|Title=Role of ERCC5 promoter polymorphisms in response to platinum-based chemotherapy in patients with advanced non-small-cell lung cancer.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}